[Form 4] Aveanna Healthcare Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Aveanna Healthcare (AVAH) — Form 4 insider transaction: On 10/24/2025, Director and 10% Owner Paul R. Vigano reported sales by affiliated entities pursuant to the option to purchase additional shares in an underwritten secondary offering. J.H. Whitney VII, L.P. sold 1,251,909 shares at $9; JHW Iliad Holdings LLC sold 224,553 shares at $9; and JHW Iliad Holdings II LLC sold 23,538 shares at $9.
Following these trades, reported indirect holdings include 19,292,787 shares via J.H. Whitney VII, L.P.; 15,523,809 via PSA Healthcare Investment Holdings LLC; 3,460,515 via JHW Iliad Holdings LLC; 1,426,034 via PSA Iliad Holdings LLC; and 362,746 via JHW Iliad Holdings II LLC.
Positive
- None.
Negative
- None.
Insights
Large shareholder/director sold shares via a secondary offering option; ownership remains significant across affiliated entities.
Paul R. Vigano (director and 10% owner) reported sales on
After these transactions, the filing shows indirect beneficial ownership of 19,292,787 Shares via J.H. Whitney VII, L.P., 15,523,809 via PSA Healthcare Investment Holdings LLC, 1,426,034 via PSA Iliad Holdings LLC, and 3,460,515 via JHW Iliad Holdings LLC, plus 362,746 via JHW Iliad Holdings II LLC. Control relationships among entities are detailed, with standard disclaimers limiting beneficial ownership to pecuniary interests.
The mechanism is a selling stockholder transaction; proceeds accrue to selling entities, not the issuer. The disclosure signals continued substantial holdings despite sales. Items to watch include any subsequent Section 16 reports or Schedule 13D/13G updates reflecting changes in aggregate holdings, and any further activity tied to the underwritten secondary offering option around
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value | 1,251,909 | $9.00 | $11.27M |
| Sale | Common Stock, $0.01 par value | 224,553 | $9.00 | $2.02M |
| Sale | Common Stock, $0.01 par value | 23,538 | $9.00 | $212K |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Footnotes (1)
- J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Paul R. Vigano is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering. On October 24, 2025, JHW Iliad Holdings LLC sold 224,553 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering. On October 24, 2025, JHW Iliad Holdings II LLC sold 23,538 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
